Ozcengiz, E. Et Al. 2022. Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice. IMMUNITY INFLAMMATION AND DISEASE , vol.10, no.12 .

Ozcengiz, E., Keser, D., ÖZCENGİZ, G., Celik, G., ÖZKUL, A., & Inceh, F. N., (2022). Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice. IMMUNITY INFLAMMATION AND DISEASE , vol.10, no.12.

Ozcengiz, Erkan Et Al. "Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice," IMMUNITY INFLAMMATION AND DISEASE , vol.10, no.12, 2022

Ozcengiz, Erkan Et Al. "Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice." IMMUNITY INFLAMMATION AND DISEASE , vol.10, no.12, 2022

Ozcengiz, E. Et Al. (2022) . "Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice." IMMUNITY INFLAMMATION AND DISEASE , vol.10, no.12.

@article{article, author={Erkan Ozcengiz Et Al. }, title={Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice}, journal={IMMUNITY INFLAMMATION AND DISEASE}, year=2022}